The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress‐related (acute‐phase) reaction
暂无分享,去创建一个
[1] C. Mantzoros,et al. Leptin: its role in obesity and beyond , 1997, Diabetologia.
[2] C. Christoffersen,et al. Insulin and Cortisol Promote Leptin Production in Cultured Human Fat Cells , 1996, Diabetes.
[3] J. Pickup,et al. Elevated Serum Sialic Acid Concentration in NIDDM and Its Relationship to Blood Pressure and Retinopathy , 1993, Diabetes Care.
[4] S. Schneider,et al. Dexamethasone increases leptin expression in humans in vivo. , 1997, The Journal of clinical endocrinology and metabolism.
[5] C. Schengrund,et al. Circulating Sialyl Compounds , 1976 .
[6] P. Zimmet,et al. Hyperleptinaemia: the Missing Link in the Metabolic Syndrome? , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[7] M. A. Crook,et al. Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.
[8] R. Considine,et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.
[9] A. Sainsbury,et al. Glucocorticoids as Counterregulatory Hormones of Leptin: Toward an Understanding of Leptin Resistance , 1997, Diabetes.
[10] L. Slieker,et al. Regulation of Expression of ob mRNA and Protein by Glucocorticoids and cAMP (*) , 1996, The Journal of Biological Chemistry.
[11] C. Mantzoros,et al. Role of leptin in the neuroendocrine response to fasting , 1996, Nature.
[12] C. Bouchard,et al. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease , 1997, Diabetologia.
[13] Y. Uchida,et al. A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants. , 1981, The Kobe journal of medical sciences.
[14] G. Brabant,et al. Determinants of serum leptin levels in Cushing's syndrome. , 1998, The Journal of clinical endocrinology and metabolism.
[15] J. Yudkin,et al. Determinants of Plasminogen Activator Inhibitor 1 Activity in Treated NIDDM and Its Relation to a Polymorphism in the Plasminogen Activator Inhibitor 1 Gene , 1995, Diabetes.
[16] R. Considine,et al. Leptin: The Tale of an Obesity Gene , 1996, Diabetes.
[17] S. Haffner,et al. Leptin Concentrations in Diabetic and Nondiabetic Mexican-Americans , 1996, Diabetes.
[18] I. Kushner. Regulation of the Acute Phase Response by Cytokines , 2015, Perspectives in biology and medicine.
[19] J. Brun,et al. Association between fibrinogen levels and insulin resistance. , 1998, Diabetes care.
[20] J. Pickup,et al. Higher Serum Sialic Acid in Women Than in Men With NIDDM: Possible Relevance to Increased Cardiovascular Risk in NIDDM Women , 1997, Diabetes Care.
[21] W. Scherbaum,et al. Evidence for a Novel Peripheral Action of Leptin as a Metabolic Signal to the Adrenal Gland: Leptin Inhibits Cortisol Release Directly , 1997, Diabetes.
[22] A. Greenberg,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .
[23] J. Pickup,et al. Serum sialic acid enzymatic assay based on microtitre plates: application for measuring capillary serum sialic acid concentrations. , 1993, British journal of biomedical science.
[24] C. Mantzoros,et al. Human leptin levels are pulsatile and inversely related to pituitary–ardenal function , 1997, Nature Medicine.
[25] S. Bornstein. Is Leptin a stress related peptide? , 1997, Nature Medicine.
[26] J. Pickup,et al. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. , 1993, Clinica chimica acta; international journal of clinical chemistry.
[27] Dennis J. Rivet,et al. Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia , 1997, The Journal of experimental medicine.
[28] G. Chrousos,et al. The effects of glucocorticoids on leptin levels in humans may be restricted to acute pharmacologic dosing. , 1998, The Journal of clinical endocrinology and metabolism.
[29] J. Friedman,et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. , 1996, The Journal of clinical investigation.